A novel radiation treatment for cancer that targets tumors from the inside using alpha particles is now in Phase 3 pivotal trials ahead of receiving Food and Drug Administration (FDA) approval.
Read more here.
![[Eko Health in PR Newswire] FIGS and Eko Health collaborate on the FIGS | Eko CORE 500™ digital stethoscope](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Eko Health in PR Newswire] FIGS and Eko Health collaborate on the FIGS | Eko CORE 500™ digital stethoscope
September 5, 2023
[Sfara in AiThority] Accedian and Sfara Announce Joint Solution to Deliver QoS Assurance for Level 3 to Level 5 Autonomous Systems
March 11, 2020
